PubRank

Jaap A Joles

Author PubWeight™ 88.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet 2012 2.74
2 Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 2007 2.69
3 Protein restriction in lactation confers nephroprotective effects in the male rat and is associated with increased antioxidant expression. Am J Physiol Regul Integr Comp Physiol 2007 2.15
4 The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 2004 2.09
5 Atorvastatin reduces sympathetic activity in patients with chronic kidney disease. J Hypertens 2011 1.52
6 Can exercise prevent preeclampsia? J Hypertens 2010 1.40
7 Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One 2012 1.36
8 Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 2004 1.36
9 Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension 2005 1.29
10 Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol 2003 1.28
11 Haemodynamic influences on kidney oxygenation: clinical implications of integrative physiology. Clin Exp Pharmacol Physiol 2013 1.28
12 In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent. Nephrol Dial Transplant 2005 1.20
13 CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol 2008 1.19
14 Oxidative stress in obstructive nephropathy. Int J Exp Pathol 2010 1.10
15 Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system? J Hypertens 2009 1.08
16 Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension 2007 1.07
17 Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol 2005 1.06
18 Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol 2010 1.04
19 Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Am J Pathol 2011 1.03
20 Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension 2004 1.02
21 Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor. Am J Physiol Renal Physiol 2005 1.01
22 Target organ cross talk in cardiorenal syndrome: animal models. Am J Physiol Renal Physiol 2012 0.99
23 Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev 2012 0.98
24 Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease. Cell Transplant 2012 0.97
25 Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol 2006 0.96
26 Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 2011 0.93
27 Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension 2004 0.92
28 IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells. Am J Physiol Cell Physiol 2010 0.92
29 Nitric oxide-dependent and nitric oxide-independent transcriptional responses to high shear stress in endothelial cells. Hypertension 2005 0.92
30 A perinatal nitric oxide donor increases renal vascular resistance and ameliorates hypertension and glomerular injury in adult fawn-hooded hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2008 0.91
31 Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion. Am J Physiol Renal Physiol 2010 0.90
32 Early determinants of cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2012 0.89
33 Blood pressure in mutant rats lacking the 5-hydroxytryptamine transporter. Hypertension 2006 0.88
34 Hypercholesterolemia in rats induces podocyte stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type 1 receptor-sensitive mechanism. J Am Soc Nephrol 2004 0.88
35 Anti-inflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: modulation of inducible nitric oxide synthase. FASEB J 2002 0.87
36 Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES study. J Nephrol 2010 0.87
37 Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats. Kidney Int 2002 0.86
38 Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. Br J Pharmacol 2015 0.86
39 Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon. Am J Physiol Renal Physiol 2004 0.86
40 Effects of gender on hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and LDL receptor in hereditary analbuminemia. Am J Physiol Endocrinol Metab 2005 0.85
41 Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney. Matrix Biol 2012 0.85
42 Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation? J Hypertens 2014 0.84
43 Male gender increases sensitivity to renal injury in response to cholesterol loading. Am J Physiol Renal Physiol 2002 0.84
44 Detection of basal NO production in rat tissues using iron-dithiocarbamate complexes. Nitric Oxide 2008 0.84
45 Perinatal micronutrient supplements ameliorate hypertension and proteinuria in adult fawn-hooded hypertensive rats. Am J Hypertens 2010 0.83
46 The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction. Am J Physiol Heart Circ Physiol 2010 0.83
47 Role of circulating karyocytes in the initiation and progression of atherosclerosis. Hypertension 2006 0.83
48 Increased expression of SOCS3 in monocytes and SOCS1 in lymphocytes correlates with progressive loss of renal function and cardiovascular risk factors in chronic kidney disease. Eur J Pharmacol 2008 0.82
49 Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension. Kidney Int 2004 0.82
50 The role of nitric oxide in renal transplantation. Semin Nephrol 2004 0.82
51 Perinatal inhibition of NF-kappaB has long-term antihypertensive effects in spontaneously hypertensive rats. J Hypertens 2011 0.82
52 Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo. Am J Physiol Renal Physiol 2007 0.81
53 5/6th nephrectomy in combination with high salt diet and nitric oxide synthase inhibition to induce chronic kidney disease in the Lewis rat. J Vis Exp 2013 0.81
54 Subtotal nephrectomy plus coronary ligation leads to more pronounced damage in both organs than either nephrectomy or coronary ligation. Am J Physiol Heart Circ Physiol 2011 0.81
55 Renal BOLD-MRI relates to kidney function and activity of the renin-angiotensin-aldosterone system in hypertensive patients. J Hypertens 2015 0.80
56 Renal venous congestion and renal function in congestive heart failure. J Am Coll Cardiol 2009 0.80
57 NO dependency of RBF and autoregulation in the spontaneously hypertensive rat. Am J Physiol Renal Physiol 2003 0.80
58 Anti-oxidant sensitivity of donor age-related gene expression in cultured fibroblasts. Eur J Pharmacol 2006 0.80
59 Hypoalbuminaemia enhances the renal vasoconstrictor effect of lysophosphatidylcholine. Nephrol Dial Transplant 2003 0.79
60 Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal. Br J Pharmacol 2014 0.79
61 Consequences of perinatal treatment with L-arginine and antioxidants for the renal transcriptome in spontaneously hypertensive rats. Pflugers Arch 2009 0.79
62 Renal sinus adiposity and hypertension. Hypertension 2010 0.79
63 Transcriptome-based identification of pro- and antioxidative gene expression in kidney cortex of nitric oxide-depleted rats. Physiol Genomics 2006 0.79
64 Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol 2010 0.78
65 A novel approach for blood purification: mixed-matrix membranes combining diffusion and adsorption in one step. Acta Biomater 2012 0.78
66 Salt sensitivity of blood pressure: developmental and sex-related effects. Am J Clin Nutr 2011 0.78
67 Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma. Biomaterials 2013 0.78
68 Renal glutathione S-transferase mu type 1 expression is already reduced in new-born spontaneously hypertensive rats. J Hypertens 2010 0.77
69 Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing. Am J Physiol Renal Physiol 2007 0.77
70 Ischemia and reactive oxygen species in sympathetic hyperactivity states: a vicious cycle that can be interrupted by renal denervation? Curr Hypertens Rep 2013 0.77
71 Bone marrow cell therapy in hypertensive kidney disease: contribution to cardiac fibrosis? J Hypertens 2013 0.77
72 Perinatal exogenous nitric oxide in fawn-hooded hypertensive rats reduces renal ribosomal biogenesis in early life. Front Genet 2011 0.77
73 Stabilization of hypoxia inducible factor-1α ameliorates acute renal neurogenic hypertension. J Hypertens 2014 0.77
74 Low albumin levels increase endothelial NO production and decrease vascular NO sensitivity. Nephrol Dial Transplant 2006 0.77
75 Effect of GFR on plasma N-terminal connective tissue growth factor (CTGF) concentrations. Am J Kidney Dis 2012 0.77
76 Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modality. Eur J Pharmacol 2008 0.77
77 Blood pressure follows the kidney: Perinatal influences on hereditary hypertension. Organogenesis 2008 0.77
78 Hypertension: Renal denervation in chronic kidney disease. Nat Rev Nephrol 2012 0.77
79 Taurine: red bull or red herring? Hypertension 2009 0.76
80 A regenerable potassium and phosphate sorbent system to enhance dialysis efficacy and device portability: an in vitro study. Nephrol Dial Transplant 2013 0.76
81 Technology insight: Innovative options for end-stage renal disease--from kidney refurbishment to artificial kidney. Nat Clin Pract Nephrol 2007 0.76
82 Hypoxanthine plus xanthine oxidase causes profound natriuresis without affecting renal blood flow autoregulation. Kidney Int 2003 0.76
83 Llama heavy-chain antibody fragments efficiently remove toxic shock syndrome toxin 1 from plasma in vitro but not in experimental porcine septic shock. Shock 2010 0.76
84 Mixed proximal and distal renal tubular acidosis without aminoaciduria in a mare. J Vet Intern Med 2007 0.76
85 Visualizing tubular lipid peroxidation in intact renal tissue in hypertensive rats. J Am Soc Nephrol 2002 0.76
86 Biological and technical considerations regarding the removal of bacteriotoxins in sepsis with emphasis on toxic shock syndrome toxin 1. Shock 2012 0.76
87 ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling. Nephron Extra 2012 0.76
88 Gene expression of energy and protein metabolism in hearts of hypertensive nitric oxide- or GSH-depleted mice. Eur J Pharmacol 2005 0.76
89 Creating a wearable artificial kidney: where are we now? Expert Rev Med Devices 2015 0.76
90 Enhanced Angiotensin II type 1 receptor expression in leukocytes of patients with chronic kidney disease. Eur J Pharmacol 2011 0.76
91 Hydrogen sulfide in hypertension. Curr Opin Nephrol Hypertens 2016 0.75
92 To D or not to D: calcitriol and vascular calcification in end-stage renal disease. J Hypertens 2005 0.75
93 The nephron number counts--from womb to tomb. Nephrol Dial Transplant 2012 0.75
94 Short-term erythropoietin treatment does not substantially modulate monocyte transcriptomes of patients with combined heart and renal failure. PLoS One 2012 0.75
95 Can exercise partly cure the cardiorenal syndrome? Clin Exp Pharmacol Physiol 2013 0.75
96 Cardiac Hepcidin Expression Associates with Injury Independent of Iron. Am J Nephrol 2016 0.75
97 Expanding the beneficial pleiotropic repertoire of interleukin-10. J Hypertens 2011 0.75
98 OS 11-04 Impact of gonadectomy on sympatho-vagal balance in male and female normotensive rat. J Hypertens 2016 0.75
99 Statins and small GTPases: Koch's postulates and chronic kidney disease. Nephrol Dial Transplant 2007 0.75
100 Removal of urea in a wearable dialysis device: a reappraisal of electro-oxidation. Artif Organs 2014 0.75
101 OS 11-04 Impact of gonadectomy on sympatho-vagal balance in male and female normotensive rat. J Hypertens 2016 0.75
102 [The wearable artificial kidney: a promise for the future?]. Ned Tijdschr Geneeskd 2013 0.75
103 Extravascular renal denervation ameliorates juvenile hypertension and renal damage resulting from experimental hyperleptinemia in rats. J Hypertens 2017 0.75